Concepedia

Publication | Closed Access

Effects of JNJ‐38431055, a novel GPR119 receptor agonist, in randomized, double‐blind, placebo‐controlled studies in subjects with type 2 diabetes

DOI

107

Citations

10

References

2012

Year

Leonid Katz, Jay J. Gambale, Paul Rothenberg, Sreenivasa R. Vanapalli, Nicole Vaccaro, Liuqing Xi, Troy C. Sarich, Peter P. Stein
Diabetes Obesity and Metabolism

Abstract

These studies provide evidence of limited glucose lowering and incretin activity for JNJ-38431055 in subjects with T2DM.

References

YearCitations

Page 1